To determine the clinical relevance of the key down-regulated genes in the gastric cancer cohort, we performed a Kaplan–Meier survival analysis and observed that patients with lower TFF1 and TFF2 levels owned shorter overall survival (OS) and tumor-free survival (TFS) time (Figures S1 and S2). This evidence concerns the gene TFF2 and gastric cancer.